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Abstract : Clinical effects of spa therapy were examined in 60 elderly asthmatics in
comparison between ex-smokers with a long history of cigarette smoking more than 20
years and never-smokers. Spa therapy was effective in 47 of the 60 subjects (78.4%)
with asthma. Ragarding the influence of cigarette smoking, the therapy was effective
in 16 of the 24 asthmatics (66.7%) with a long history of cigarette smoking. In con-
trast, the therapy was effective in 31 of the 36 asthmatics (86.1 %) without smoking
history. The spa efficacy was significantly larger in asthmatics without smoking history
than those with (p<0.05). There was no significant correlation between spa efficacy
and IgE-mediated reactions. Bronchial hyperresponsiveness was significantly higher in
subjects with slight or no efficacy of spa therapy than in those with marked and mod-
erate efficacy both in ex-smokers and never-smokers as well as in total subjects. The
generation of leukotriene B4 (LTB4) by leucocytes was significantly increased in sub-
jects with slight or no efficacy of spa therapy than in those with marked and moderate
efficacy in total subjects and in those with smoking history, but not in those without
smoking history. The generation of leukotriene C4 (LTC4) by leucocytes was not sig-
nificantly correlated with spa efficacy in total subjects, and also either in ex-smokers
or never-smokers. The results demonstrate that clinical effects of spa therapy are in-
fluenced by long-term cigarette smoking, which increases bronchial hyperrespon-
siveness and the generation of LTB4 by leucocytes.
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Introduction
Cigarette smoking as well as aging influences
the pathophysiology of asthma in the elderly I - 3) :
cigarette smoking increases immunoglobulin (Ig)
E-mediated allergy, bronchial hyperresponsive-
ness, and generation of leukotriene B4 (LTB4),
but not leukotriene C4 (LTC4). Cigarette smok-
ing increases the inflammatory burden of the
lower respiratory tract through a number of
related, but separate mechanisms. These in-
clude the recruitment of increased numbers of
inflammatory cells, alteration in cell sub-types,
enhancement of some cellular functions, and
pro-inflammatory mediator releaseS). Exposure
to cigarette smoke increases sensitization to food
allergens in the few years of life 6) , but not as-
sociated with sensitization to inhaled allergens 7) •
However, cigarette smoke exposure enhances
existing symptoms of allergic airway reactions
such as bronchial hyperresponsiveness B).
Cigarette smoking is also known to be closely
related to the onset mechanisms of chronic ob-
structive pulmonary disease 9 . 10). An association
between smoke exposure and the induction 11) or
exacerbation of asthma has been reported 12) •
Regarding adult asthma, a recent case-control
study showed that adult onset of asthma was
not associated with a history of smokingB). In
contrast, current smoking has been shown to
increase asthma severityl3), and higher inci-
dences of asthma are found in current and for-
mer smokers, compared with never- smokers14-16).
It has been shown that spa therapy is effective
in patients with asthmaI7-25), even in asthmatics
with an increased low attenuation area (IAA) of
the lungs on high resolution computed
tomography (HRCT) and an increase in residual
volume26-28), as well as in those with pulmonary
emphysema29-3IJ . However, the influence of
cigarette smoking on effects of spa therapy for
elderly asthmatics still remains unclear.
In the present study, the influence of ciga-
rette smoking on effects of spa therapy for asth-
matics in the elderly was examined in relation
to IgE-mediated allergy, bronchial hyperrespon-
siveness and generation of LTB4 and LTC4 by
leucocytes.
Subjects and Methods
The subjects of this study was 60 patients
with asthma (26 females and 34 males). Their
age was all over 65 years (mean age 71. 4 years).
Twenty four of them had a long history of ciga-
rette smoking more than 20 years (mean 41. 4
pack-year). All of them were ex-smokers, and
residual 36 were never-smokers. All subjects had
spa therapy including swimming training in a hot
spring poops. 32) , fango therapy and inhalation with
iodine salt solution33) at Misasa Medical Center
for 1-3 months. The efficacy of spa therapy was
evaluated by comparing their symptoms and pul-
monary function before and after the therapy. The
efficacy was assessed in four degrees, marked,
moderate, slight and no efficacy. The efficacy
was evaluated to be effective for subjects with
marked and moderate efficacy.
Serum IgE level was measured by immuno-
sorbent test (RIST) , and IgE antibodies against
inhalant allergens including house dust mite,
pollens, moulds, and animal danders were meas-
ured using the Pharmacia CAP system
(Pharmacia Diagnostic AB, Upsalla, Sweden).
Bronchial hyperresponsiveness to methacholine
was measured by an Astograph (TSK6100,
Chest Co.) before spa therapy. Different con-
centration of methacholine (49, 98, 195, 390,
781, 1563, 3125, 6250, 12,500 and 25,000,u g
/ m!) were prepared for bronchial challenge ac-
cording to the method used by Chai et al. 34).
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Table 1. Clinical effects of spa therapy and serum IgE level in
asthmatics in the elderly
Serum IgE level was not significantly corre-
lated with the efficacy of spa therapy in total
subjects and either in ex-smokers or never-
smokers (Table 1 ) .
with smoking history (4 with marked efficacy
and 12 with moderate, efficacy rate 66.7%). In
contrast, the efficacy was observed in 31 of the
36 patients without smoking history (6 with
marked efficacy and 25 with moderate, efficacy
rate 86.1%). The efficacy rate of spa therapy
was significsantly higher in patients without a
history of smoking than in those with a long
history of smoking (p<0.05) (Fig. 1).
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Clinical efficacy
Marked Moderate slight or no
-_._--~----
Total subjects 571
,
227 399
(47-2929) (2-2918) (2-2350)
Ex-smokers 921 334 500
(20-2929) (9-1480) (19-2350)
Never-smokers 337 323 222
(160-880) (9-2918) (54-461)
Total subjects
(n=60)
Ex-smokers
(n=24)
Never-smokers
(n=36)
Fig.1. Clinical effects of spa therapy for asthmatics in the
elderly. (. ): marker efficacy, ( ~~): moderate
efficacy, and ( D ): slight or no efficacy. 'p<0.05.
The increase of total respiratory resistance
(Rrs) after methacholine inhalation was meas-
ured by the oscillation method. A methacholine
concentration causing significant increase in Rrs
was assessed as Cmin (minimum concentration).
All medications were stopped 12 hours prior
to examination.
The generation of LTB4 and LTC4 by the pe-
ripheral leucocytes was assessed as previously
described35·37). Five milliliters of 6 % dextran
(molecular weight -200,000 kDa) (Nacalai Te-
que., Inc, Kyoto) were added to 20 m1 of hepari-
nized peripheral blood, and the mixture was left
for 1 hour at room temperature. The leucocytes-
rich plasma supematant was then removed and
used. The number of cells was adjusted to 5x10 6
cells/ml in Tris CM, and 1 p. g of calcium
ionophore A 23187 (Sigma, St Louis, Mo, USA)
was then added to the cell suspension. The solu-
tion was mixed and incubated for 15 minutes at
3TC. After a 4x volume of pre-chilled ethanol
(final, 80% ethanol) was added. This was centri-
fuged at 3,000 rpm for 30 minutes. The filtrate
through a syringe filter (Toyo Roshi Co., Tokyo)
was decompressed and dried to solid. LTB4 and
LTC4 were quantified by means of high-per-
formance liquid chromatography, as described
by Lam et al. 38). Quantities of LTB4 and LTC4
were expressed as nanogram per 5x10 6 cells.
Statistically significant differences of the mean
were estimated using the unpaired Student's t
test and X 2 test. A p value of <0.05 was re-
garded as significant.
Results 'tU/m;
The clinical effects of spa therapy were observed
in 47 of the 60 elderly asthmatics (10 patients
with marked efficacy and 37 with moderate).
The efficacy rate was 78. 4%. The efficacy of
spa therapy was found in 16 of the 24 patients
The number of patients with a positive RAST
score against inhalant allergens was not signifi-
cantly different among subjects with marked,
moderate, and slight or no efficacy. However,
the frequency of patients showing a positive
RAST score was significantly higher in ex-
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Table 2. Clinical effects of spa therapy and specific IgE antibodies
against inhalant allergens in asthmatics in the elderly
smokers than in never-smokers of patients with
moderate efficacy (Table 2 ) .
Clinical efficacy
Marked Moderate slight or no
._-~~--~.
Total subjects 6/10 * 23/37 8/13
(60.0%) (62.2%) (61.5%)
*No of patients with a positive RAST score against inhalant
allergens. a:p<O.OS.
Ex-smokers
Never-smokers
3/4
(75.0%)
3/6
(50.0%)
11/12 a
(91.7%)
12/25 a
(48.0%)
6/8
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2/5
(40.0%)
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Fig.2. Bronchial hyperresponsiveness and clinical effects of
spa therapy in asthmatics in the elderly. (e ): ex-
smokers, (0): never-smokers. a and b:p<O.Ol, c and
d:p<0.05, e:p<0.02.
Bronchial hyperresponsiveness to methacholine
was significantly larger in patients with slight or
no efficacy compared with that in those with
marked (p<O.OO1) and moderate efficacy (p<
0.001) in all subjects. The hyperresponsiveness
was also significantly higher in subjects with
slight or no efficacy than in subjects with
marked and moderate efficacy in each group of
ex-smokers and never-smokers. Furthermore,
bronchial hyperresponsiveness was significantly
higher in patients with a history of smoking
than in those without in subjects with moderate
efficacy (p<0.02) (Table 3). The responsive-
ness tended to decrease as clinical effects of spa
therapy became predominant (Fig. 2).
Table 3. Bronchial hyperresponsiveness to methacholine and clinical
effects of spa therapy in asthmatics in the elderly
Clinical efficacy
Marked Moderate slight or no
*a 1612 b 276 abTotal subjects 1269
( ±810) (± 1659) ( ±191)
Ex-smokers 828 c 659 dg 168 ed
( ±S63) (±469) (±101)
Never-smokers 1562 e 2070 lg 308 el
( ±856) ( ±1834) ( ±290)
*Methacholine concentration (,Lg/ml). a and b: p<O.OOl,
c and d: p<0.01, e: p<0.02, f: p<0.05, g: p<0.02.
The generation of LTB4 was significantly
larger in patients with slight or no efficacy than
in those with marked (p<O.OO1) and moderate
efficacy (p< O. 001) in all subjects. Regarding
cigarette smoking, .the LTB4 generation was
significantly more increased in patients with
slight or no efficacy than in those with marked
(p<O.OI) and moderate efficacy (p<O.01) in
ex-smokers, but no significant correlation was
found between LTB4 generation and spa efficacy
in never-smokers. The LTB4 generation was
also significantly larger in ex-smokers than in
never-smokers of patients with moderate efficacy
(Table 4).
Table 4. Leukotriene 84 generation by leucocytes and clinical
effects of spa therapy in asthmatics in the elderly
Clinical efficacy
Marked Moderate slight or no
Total subjects 76.9 *a 82.2 b 111.6 ab
( ±27.1) (±30.8) (±29.0)
75.0 c 103.4 de
cd
Ex-smokers 128.9
(±44.3) (±17.4) ( ±19.4)
Never-smokers 61.8 72.0 e 84.0
( ±23.9) ( ±30.9) (±18.1)
*ng/5x1 0 6cells. a and b:p<O.OOl, c,d, and e:p<O.Ol.
The generation of LTB4 showed a tendency to
increase as the spa effects became less in ex-
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smokers, but not in never-smokers (Fig. 3).
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Fig.3. Leukotriene 84 generation by leucocytes and clinical
effects of spa therapy in asthmatics in the elderly.
( • ): ex-smokers, (0 ): never-smokers. a and b: p<
0.Q1.
The LTC4 generation was not significantly
correlated with spa efficacy in all subjects, and
either in ex-smokers or never-smokers. The
LTC4 generation was significantly larger in
never-smokers than in ex-smokers of patients
with moderate efficacy (Table 5 ) .
Table 5. Leukotriene C4 generation by leucocytes and clinical
effects of spa therapy in asthmatics in the elderly
Clinical efficacy
Marked Moderate slight or no
-~----,..
Total subjects 42.5* 40.6 54.2
( ±31.6) ( ±2B.O) ( ±31.4)
Ex-smokers 63.2 48.6 a 49.4
( ±31.6) ( ±23.3) ( ±3B.7)
Never-smokers 28.6 71.5 a 62.0
( ±2S.0) ( ±30.9) ( ±14.B)
*ng/5xl 0 6cells. a:p<O.OS.
Discussion
Spa therapy is effective for patients with
asthma17·25.39). Spa effects have been observed in
asthmatics in the elderly'Ol and in those with
hypersecretion 41l and with bronchiolar ob-
struction'2). Spa therapy is also effective in
asthmatics with emphysematous changes such
as an increase in residual volume26·28) and in pa-
tients with pulmonary emphysema29-31l • However,
clinical effects of spa therapy for patients with
asthma and/or pulmonary emphysema are in-
fluenced by various conditions found in the
pathophysiological changes of these diseases .
Of various conditions affecting spa effects, aging,
IgE-mediated allergy, and cigarette smoking
have been noticed in recent years 1 - 3). Aging in-
fluences the pathophysiology of asthma : an in-
crease in LAA of the lungs on HRCT and an in-
crease in residual volume (RV) are observed
with aging'3.44). IgE-mediated allergy also influ-
ences the pathophysiology of asthma by enhanc-
ing the generation of LTC4 36).
In the present study, the influence of ciga-
rette smoking on the effects of spa therapy was
examined in asthmatics in the elderly. The clini-
cal efficacy of spa therapy was significantly
higher in never-smokers of asthmatics than in
those with a long history of smoking. There
was no significant difference in serum IgE levels
between patients with spa efficacy and those
without. The frequency of patients with a posi-
tive RAST score against inhalant allergens was
not correlated with the efficacy of spa therapy,
although the frequency of these patients was
significantly larger in ex-smokers compared with
never- smokers. Bronchial hyperresponsiveness
to methacholine was significantly higher in pa-
tients with slight or no efficacy than in those
with moderate and marked efficacy both in ex-
smokers and never-smokers. The bronchial
hyperresponsiveness was significantly higher in
ex-smokers than in never-smokers of asthmat-
ics with moderate efficacy. The results demon-
strate that the long-term cigarette smoking en-
hances bronchial hyperresponsiveness, and that
bronchial hyperresponsiveness is closely related
to spa efficacy in asthmatics in the elderly.
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Regarding the generation of LTB4 and LTC4
by leucocytes, the LTB4 generation was signifi-
cantly larger in patients with slight or no effi-
cacy compared with those with marked and
moderate efficacy in ex-smokers, but not in
never-smokers. The LTB4 generation was sig-
nificantly larger in ex-smokers than in never-
smokers in asthmatics with moderate efficacy of
spa therapy. The LTC4 generation was not sig-
nificantly related to spa efficacy. The results .
suggest that cigarette smoking enhances IgE-
mediated allergy, bronchial hyperresponsiveness,
and LTB4 generation by leucocytes in asthmat-
ics in the elderly (Table 6 ), and that these
changes is closely correlated with spa efficacy.
Table 6. Influence of cigarette smoking on IgE-mediated
allergy. bronchial hyperresponsiveness and LTB4,
LTC4 generation an asthmatics in the elderly
Ex-smokers Never-smokers
IgE-mediated t --.allergy
Bronchial t --.hyper- .
responsIveness
LTB4 ..
--.generation I
LTC4
--. --.generation
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高齢者気管支嘱息における喫煙による気道過敏性
の瓦進と温泉療法の岳床効果
光延文裕,保崎泰弘,芦田耕三,岩垣尚史,
藤井 誠,高田真吾,清田全紀 1),谷崎勝朗
岡山大学医学部 ･歯学部附属病院三朝医療センター
内科, 1)リハビリテーション科
高齢者哨息60例を対象に,長期的喫煙の温泉療
法の効果に及ぼす影響について検討した｡温泉療
法は60例中47例(78.4%)に有効であった｡喫煙の
影響については,喫煙歴の有る24例中16例(66.7%)
で温泉療法は有効であったが,一方,非喫煙例36例
26
44.MitsunobuF,HosakiY,AshidaK,etal.:
Efectsofagingonbronchoalveolar lavage
(BAL)celsinpatientswi仇as血ma.AnnRep
MisasaMedCenter,OkayamaUnivMedSch
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では31例 (86.1%)で有効であり,温泉療法の有
効性は非喫煙例で有意に高いことが示された｡温
泉療法の有効性とIgE系反応との間には有意の関
連はみられなかった｡気道過敏性は喫煙例,非喫
煙例いずれにおいても,有効例 (著効ないし有効)
に比べ無効例 (ややで有効ないし無効)において
有意に高い傾向を示したo LTB4産生は喫煙例で
は,無効例で有効例と比べ有意の元進が見られた
が,非喫煙例では関連は見られなかった｡これら
の結果は,長期間の喫煙が,気道過敏性や白血球
のLTB4産生を克進させ,その結果として温泉療
法の臨床効果に影響を与える可能性が高いことを
示しているものと考えられる｡
